【百利天恒:擬募資不超過37.64億元全部用于創(chuàng)新藥研發(fā)】《科創(chuàng)板日?qǐng)?bào)》30日訊,百利天恒(688506.SH)公告稱,公司計(jì)劃向特定對(duì)象發(fā)行A股股票并募集資金不超過37.64億元,扣除發(fā)行費(fèi)用后,實(shí)際募集資金將全部用于創(chuàng)新藥研發(fā)項(xiàng)目。
特別聲明:以上內(nèi)容(如有圖片或視頻亦包括在內(nèi))為自媒體平臺(tái)“網(wǎng)易號(hào)”用戶上傳并發(fā)布,本平臺(tái)僅提供信息存儲(chǔ)服務(wù)。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.